Parsons Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Buy
94,146
+7,054
+8% +$826K 0.55% 36
2026
Q1
$10.5M Buy
87,092
+3,511
+4% +$405K 0.48% 44
2025
Q4
$8.8M Sell
83,581
-14,477
-15% -$1.36M 0.48% 41
2025
Q3
$8.23M Sell
98,058
-5,294
-5% -$436K 0.47% 41
2025
Q2
$8.18M Sell
103,352
-67,825
-40% -$5.39M 0.5% 40
2025
Q1
$15.4M Sell
171,177
-2,995
-2% -$280K 0.84% 26
2024
Q4
$17.3M Buy
174,172
+48,662
+39% +$5.02M 0.94% 20
2024
Q3
$14.3M Sell
125,510
-394
-0.3% -$46.8K 0.9% 23
2024
Q2
$15.6M Sell
125,904
-909
-0.7% -$117K 1.06% 18
2024
Q1
$16.7M Buy
126,813
+2
+0% +$247 1.15% 16
2023
Q4
$13.8M Sell
126,811
-1,233
-1% -$128K 0.99% 18
2023
Q3
$13.2M Buy
128,044
+810
+0.6% +$87.3K 1.04% 18
2023
Q2
$14.7M Sell
127,234
-14
-0% -$1.59K 1.12% 15
2023
Q1
$13.5M Buy
127,248
+4,952
+4% +$535K 1.09% 17
2022
Q4
$13.6M Buy
122,296
+6,143
+5% +$628K 1.13% 16
2022
Q3
$10M Buy
116,153
+16,779
+17% +$1.5M 0.9% 19
2022
Q2
$9.06M Buy
99,374
+5,834
+6% +$517K 0.81% 24
2022
Q1
$7.67M Sell
93,540
-692
-0.7% -$54.6K 0.58% 37
2021
Q4
$7.22M Sell
94,232
-195
-0.2% -$15.5K 0.52% 39
2021
Q3
$7.09M Sell
94,427
-1,700
-2% -$129K 0.55% 37
2021
Q2
$7.48M Sell
96,127
-4,716
-5% -$351K 0.57% 36
2021
Q1
$7.42M Sell
100,843
-340
-0.3% -$25.1K 0.61% 34
2020
Q4
$7.9M Buy
101,183
+601
+0.6% +$46K 0.68% 30
2020
Q3
$7.96M Buy
100,582
+451
+0.5% +$35.3K 0.78% 25
2020
Q2
$7.39M Sell
100,131
-1,415
-1% -$107K 0.79% 26
2020
Q1
$7.46M Sell
101,546
-4,839
-5% -$380K 0.96% 21
2019
Q4
$9.23M Sell
106,385
-707
-0.7% -$58.1K 0.93% 20
2019
Q3
$8.6M Buy
107,092
+1,461
+1% +$117K 0.93% 22
2019
Q2
$8.45M Sell
105,631
-305
-0.3% -$23.4K 0.92% 22
2019
Q1
$8.41M Buy
105,936
+1,469
+1% +$110K 0.92% 22
2018
Q4
$7.62M Sell
104,467
-520
-0.5% -$36.7K 0.94% 23
2018
Q3
$7.11M Sell
104,987
-279
-0.3% -$17.8K 0.75% 26
2018
Q2
$6.1M Buy
105,266
+2,074
+2% +$117K 0.69% 28
2018
Q1
$5.36M Sell
103,192
-804
-0.8% -$43.4K 0.62% 35
2017
Q4
$5.58M Sell
103,996
-672
-0.6% -$37.3K 0.62% 32
2017
Q3
$6.39M Sell
104,668
-342
-0.3% -$20.7K 0.75% 27
2017
Q2
$6.42M Buy
105,010
+342
+0.3% +$20.8K 0.78% 24
2017
Q1
$6.35M Sell
104,668
-1,786
-2% -$108K 0.8% 26
2016
Q4
$5.98M Sell
106,454
-524
-0.5% -$30.7K 0.79% 28
2016
Q3
$6.37M Sell
106,978
-2,043
-2% -$119K 0.86% 26
2016
Q2
$5.99M Sell
109,021
-1,571
-1% -$83.6K 0.82% 27
2016
Q1
$5.58M Sell
110,592
-126
-0.1% -$6.17K 0.76% 28
2015
Q4
$5.58M Buy
110,718
+1,948
+2% +$98.2K 0.78% 29
2015
Q3
$5.13M Sell
108,770
-2,358
-2% -$125K 0.75% 31
2015
Q2
$6.04M Sell
111,128
-89
-0.1% -$4.99K 0.8% 23
2015
Q1
$6.1M Sell
111,217
-533
-0.5% -$30.2K 0.86% 21
2014
Q4
$6.06M Buy
111,750
+393
+0.4% +$21.9K 0.8% 25
2014
Q3
$6.3M Sell
111,357
-233
-0.2% -$13.1K 0.87% 21
2014
Q2
$6.16M Sell
111,590
-1,991
-2% -$109K 0.85% 23
2014
Q1
$6.15M Buy
113,581
+10,809
+11% +$560K 0.87% 19
2013
Q4
$4.91M Sell
102,772
-2,442
-2% -$112K 0.74% 32
2013
Q3
$4.78M Buy
105,214
+1,348
+1% +$61.5K 0.78% 31
2013
Q2
$4.6M Buy
+103,866
New +$4.64M 0.79% 30

Other funds holding MRK

Parsons Capital Management's MRK Position: Q2 2026 in Review

Parsons Capital Management increased its Merck (MRK) stake by 8.1% in Q2 2026, buying an estimated $826K and bringing the position to 94,146 shares worth $12.1M. The position accounts for 0.55% of the portfolio, ranked #36.

Parsons Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.3M in Q4 2024. 1,561 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Parsons Capital Management held 94,146 shares of Merck worth $12.1M as of Q2 2026.
  • Parsons Capital Management bought 7,054 Merck shares in Q2 2026, an estimated $826K.
  • Merck made up 0.55% of Parsons Capital Management's portfolio in Q2 2026, its #36 holding.
  • Parsons Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Parsons Capital Management's Merck position peaked at $17.3M in Q4 2024.
  • 1,561 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.